InSilicoTrials Recognized in the HSBC 2024 Annual Venture Healthcare Report

HSBC Venture Healthcare

InSilicoTrials is featured in HSBC's 2024 Venture Healthcare Report, which highlights the most promising healthcare startups globally across diagnostics, therapeutics, and digital health.